Clin2
NCT07531043Possibly a fitNot yet recruiting

Eye drops for red eyes in adults

Ocular Hyperemia

Part of Eyes & vision clinical trials.

This trial tests an eye drop that may reduce redness in adults who often use redness relief drops or are interested in them. If you qualify, you might get either the study drop or a placebo to see if it works.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
230 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You often use redness relief drops, want to try them, or your doctor thinks they could help you.
  • You have noticeable eye redness (a score above 1.0 on a 5-point scale) in both eyes at the start.
  • You have not had eye surgery in the last 6 months.
  • You are generally healthy with normal blood pressure, pulse, and eye pressure.
  • You are willing to follow the study schedule and attend all visits.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07578363Not yet recruiting· Phase 3
Eye drops for reducing eye redness in adults

This study tests an experimental eye drop to see if it can reduce eye redness compared to a placebo drop. If you often use redness relief drops or would like to, this trial might help you find a new option.

Fort Worth, Texas
NCT07209410Recruiting· Phase 4
Eye drops to reduce redness from glaucoma treatment

This trial tests if adding brimonidine eye drops can reduce eye redness caused by the glaucoma drops you are currently taking. It may help if you have been using netarsudil/latanoprost drops and have noticed redness.

Kansas City, Missouri
NCT07778888Not yet recruiting· Phase 2
Adjustable treatment for eye redness in dry eye disease

This study tests an eye drop that may reduce redness and irritation in people with dry eye disease. It looks at different doses to find the best treatment for each person.

NCT07764965Not yet recruiting· Phase 1
Eye drop safety study in healthy adults

This study tests a new eye drop medicine to see if it is safe and how the body handles it. It is for healthy adults only, not for treating a condition.

NCT06514612Recruiting· Phase 3
Eye drop study for droopy eyelids in adults

This study tests a new eye drop (oxymetazoline) to see if it can help lift droopy eyelids in adults. To join, you must have a certain amount of eyelid droop and some vision loss in your upper field of view, and you should feel that the droop bothers you enough to want treatment.

Pardubice
NCT04007276Not yet recruiting· Phase 4
Check if Lumify changes eye redness and pressure in glaucoma

This study tests whether Lumify™ eye drops affect eye redness, eye pressure, and eyelid position in people with primary open-angle glaucoma. It may help doctors understand how “whitening” eye drops could interact with glaucoma treatment and symptoms.

New Orleans, Louisiana

Hear when a new Ocular Hyperemia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.